Ai Ling Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ai Ling Wang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Albert C.H. Yu
Neuroscience Research Institute, Peking University; Key Laboratory of Neuroscience (PKU), Ministry of Education and Department of Neurobiology, Peking University Health Science Center, Beijing 100083, China
2 shared publicationsMark O.M. Tso
Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
2 shared publicationsA Yu
1 shared publicationAn-Min Cao
1 shared publicationC Lee
Department of Immunology|Peking University|Health Science Center
1 shared publicationL Wu
1 shared publication
Latest Publications
- 1 December 2007
- Published by Elsevier in International Immunopharmacology
- Vol. 7 (12) , 1552-1558
Sinomenine inhibits activation of rat retinal microglia induced by advanced glycation end products
- 1 December 2007
- Published by Elsevier in International Immunopharmacology
- Vol. 7 (12) , 1552-1558
Sinomenine inhibits activation of rat retinal microglia induced by advanced glycation end products
- 1 May 2007
- Published by Elsevier in Experimental Eye Research
- Vol. 84 (5) , 905-913
AGEs mediated expression and secretion of TNF alpha in rat retinal microglia
- 1 May 2007
- Published by Elsevier in Experimental Eye Research
- Vol. 84 (5) , 905-913
AGEs mediated expression and secretion of TNF alpha in rat retinal microglia
- 1 July 2005
- Published by Elsevier in Neurochemistry International
- Vol. 47 (1-2) , 152-158
Minocycline inhibits LPS-induced retinal microglia activation
- 1 July 2005
- Published by Elsevier in Neurochemistry International
- Vol. 47 (1-2) , 152-158
Minocycline inhibits LPS-induced retinal microglia activation
- 18 April 2005
- Vol. 37 (2) , 198-200
[Establishment of a model of retinal microglial cells activation in vitro].
To develop a method of retinal microglial cell culture to study the function of the microglial cell in diabetic retinopathy. Microglia were activated with LPS. Immunocytochemistry, con-focal microscopy, flow cytometry, MTT and ELISA were applied to observe the morphological characters, quantity, and functional changes of the microglia. The purity of the microglia was up to 96% as determined by immunostaining and flow cytometry. Some morphological changes of microglia were observed after treatment with LPS, but their quantity kept stable. Cytokine TNF-alpha released from microglia increased significantly. The isolated microglial cells are pure by using this culture system, which would provide a valuable tool for studying mechanisms of microglial alterations in diabetic retinopathy.
- 18 April 2005
- Vol. 37 (2) , 198-200
[Establishment of a model of retinal microglial cells activation in vitro].
To develop a method of retinal microglial cell culture to study the function of the microglial cell in diabetic retinopathy. Microglia were activated with LPS. Immunocytochemistry, con-focal microscopy, flow cytometry, MTT and ELISA were applied to observe the morphological characters, quantity, and functional changes of the microglia. The purity of the microglia was up to 96% as determined by immunostaining and flow cytometry. Some morphological changes of microglia were observed after treatment with LPS, but their quantity kept stable. Cytokine TNF-alpha released from microglia increased significantly. The isolated microglial cells are pure by using this culture system, which would provide a valuable tool for studying mechanisms of microglial alterations in diabetic retinopathy.